Transgene to Present at the 2nd Rodman & Renshaw Annual Global Healthcare Conference
26 April 2005 - 3:01PM
PR Newswire (US)
Transgene to Present at the 2nd Rodman & Renshaw Annual Global
Healthcare Conference STRASBOURG, France, April 26
/PRNewswire-FirstCall/ -- Transgene (Nasdaq: TRGNY; Eurolist Paris:
FR0005175080) today announced that Dr. Philippe Archinard, Chief
Executive Officer, will present at the 2nd Rodman & Renshaw
Annual Global Healthcare Conference, on Wednesday May 4, 2005, at
3:10pm at the Intercontinental Hotel in Paris, France. Dr. Philippe
Archinard will provide an overview of Transgene's strategy,
clinical programs and corporate objectives for 2005. A web cast of
Dr. Archinard's presentation will be available live and afterward
at:
http://www.rodmanandrenshaw.com/rodman.asp?link=Conferences5/ConferenceWebcast
ers&bgcolor=wht Transgene, based in Strasbourg, France, is a
biopharmaceutical company dedicated to the discovery and
development of therapeutic vaccines and immunotherapy products for
the treatment of cancer and infectious diseases. Transgene has a
broad portfolio of products in clinical development. DATASOURCE:
Transgene CONTACT: Philippe Poncet, Chief Financial Officer and
Investor Relations of Transgene, +33-0-3-88-27-91-21; or Michael
Long of Cohn & Wolfe, +1-415-365-8523; or Tiphaine
Hecketsweiler of Image 7, +33-0-1-53-70-74-70, both for Transgene
Web site: http://www.transgene.fr/
Copyright